Compositions and methods for treating Alzheimer's disease
Abstract:
Provided herein are antibodies against amyloid-beta (Aβ) oligomers, and methods of use thereof for the treatment of Alzheimer's disease (AD). In particular, neuronal expression of single-chain variable fragment (scFv) antibodies against Aβ oligomers is provided as a therapeutic approach in the treatment of AD.
Public/Granted literature
Information query
Patent Agency Ranking
0/0